|
MEdication
|
Standard admixture
|
Maximum concentration (via central line) or special infusion
instructionS
|
|
Abciximab
(Reoprỏ)
|
IV bolus: may be given undiluted
(2
mg/mL vial)
Infusion: 10 mg/250 mL in D5W
(40
mcg/mL)
|
Must be filtered with a 0.2m filter before
administering the bolus and the infusion.
12 hour expiration time, D5W or NS
Patients may also receive heparin
|
|
Alprostadil
|
1 mcg/mL in NS
(250 mcg/250 mL, 500 mcg/500 mL)
|
Various volumes may be used for final concentrations 1-20
mcg/mL
D5W or NS
24 hour stability
|
|
Alteplase
(TPA)
|
Arterial occlusion:
0.1 mg/mL in NS
Catheter
clearance: 2 mg or 2.5 mg syringes available from pharmacy. May be used in all patient care areas.
|
Various volumes used based on rate and anticipated
infusion time
24 hour stability
(usual dose = 0.25-1 mg/hr x 6-24 hrs)
|
|
Amiodarone
(Cordaronẻ)
|
Load: 150 mg/100 mL D5W bag
(1.5
mg/mL)
Infusion: 900 mg/500 mL D5W glass
(1.8
mg/mL)
Cardiac arrest: 300 mg or 5 mg/kg
bolus,
flush with 10mL D5W
(50
mg/mL amp)
|
1-6 mg/mL (900 mg/150 mL)
PVC bags only suitable for loading doses
Glass containers used for solutions given
over more than 2 hours
|
|
Argatroban
For
HIT (heparin-induced thrombocytopenia)
|
1 mg/mL in NS
(125 mg/125 mL, 250 mg/250 mL)
Must be properly protected from light
|
1 mg/mL
NS or D5W
24 hour stability
Monitor aPTT and adjust dose as needed
|
|
Bumetanide
(Bumex̉)
|
0.25 mg/mL undiluted drug
(24 mg/96 mL)
Must be properly protected from light
|
May be further diluted per request
D5W or NS
|
|
Cisatracurium
(Nimbex̉)
|
IV bolus: may be given undiluted
(10
mg/mL vial)
Infusion: 200 mg/100 mL NS
(2
mg/mL)
|
2 mg/mL
NS or D5W
Train-of-Four monitoring
|
|
Diltiazem
(Cardizem̉)
|
IV bolus: may be given undiluted
(5
mg/mL vial)
Infusion: 100 mg/100 mL D5W
(1
mg/mL)
|
1 mg/mL
D5W or NS
|
|
Dobutamine
|
(4000 mcg/mL)
Premade:
250/500/1000 mg in 250 mL D5W
|
5000 mcg/mL (1250
mg/250 mL)
D5W or NS
Some institutions report up to
8000 mcg/mL (2000 mg/250 mL)
|
|
Dopamine
|
400 mg/250 mL D5W
(1600 mcg/mL)
Premade:
400/800 mg in 250 mL D5W
|
3200 mcg/mL (800
mg/250 mL)
D5W or NS
Some institutions report up to
6400 mcg/mL (1600 mg/250 mL)
|
|
Epinephrine
|
4 mg/250 mL D5W
(16 mcg/mL)
|
2-120 mcg/mL in D5W or NS
(30 mg/250 mL for ACLS)
|
|
Eptifibatide
(Integrilin̉)
|
IV bolus: may be given undiluted
(2
mg/mL vial)
Infusion: 75 mg/100 mL pre-made
(0.75mg/mL)
|
Patients may also receive heparin
|
|
Esmolol
(Brevibloc̉)
|
IV bolus: may be given undiluted
**only use 10 mg/mL amp for this**
Infusion: 10 mg/mL in D5W
(2500 mg/250 mL, 5000 mg/500 mL)
|
10 mg/mL in D5W or NS
Some institutions report up to
20 mg/mL (5000 mg/250 mL)
|
|
Fenoldopam
(Corlopam̉)
Must meet guideline criteria for use
|
40 mcg/mL in NS
(10 mg/250 mL, 20 mg/500 mL)
|
200 mcg/mL in NS or D5W
(20 mg/100 mL)
Manufacturer states up to 273 mcg/mL
|
|
Fentanyl
|
Infusion: 10 mcg/mL in NS
(1000 mcg/100 mL)
PCA: 50 mcg/mL undiluted drug
(2500
mcg/50 mL)
Epidural: 2.5, 5 or 10 mcg/mL with bupivicaine 0.125% in
250 mL NS
|
50 mcg/mL undiluted drug
May be further diluted per request
|
|
Furosemide
(Lasix̉)
|
10 mg/mL undiluted drug
(1000 mg/100 mL)
Must be properly protected from light
|
May be further diluted per request:
1-10 mg/mL
D5W or NS
|
|
Heparin
|
40 units/mL in D5W
(20,000 units/500 mL)
|
Various concentrations given for IV use
Maximum infusion concentration
200 units/mL
|
|
Hydromorphone
(Dilaudid̉)
|
PCA: 40 mg/200 mL NS
(0.2
mg/mL)
|
10 mg/mL undiluted
May be diluted per request to yield various concentrations
for PCA or continuous infusion, D5W or NS
|
|
Insulin, regular
|
1 unit/mL in NS
(100 units/100 mL)
|
0.1-1 unit/mL in NS or ½NS
|
|
Isoproterenol
(Isuprel̉)
|
1 mg/250 mL D5W
(4 mcg/mL)
|
20 mcg/mL in D5W or NS
Some institutions report up to
40 mcg/mL (10 mg/250 mL)
|
|
Lepirudin
(Refludan̉)
For
HIT (heparin-induced thrombocytopenia)
|
IV bolus: 5 mg/mL in NS
(prepared in syringe)
Infusion: 100 mg/500 mL NS
(0.2 mg/mL)
|
100 mg/250 mL NS or D5W
(0.4 mg/mL)
24 hr stability
Monitor aPTT and adjust dose if needed
|
|
Lidocaine
(Xylocainẻ)
|
4000 mg/500 mL D5W
(8 mg/mL)
|
8 mg/mL in D5W
Some institutions report up to
16 mg/mL (4000 mg/250 mL)
|
|
Lorazepam
(Ativan̉)
|
1 mg/mL in D5W glass bottle only
(40 mg/40 mL, 80 mg/80 mL)
Must be properly protected from light.
|
0.1, 0.2 and 1 mg/mL
D5W or NS glass bottle
Short stability, depends on final concentration
|
|
Midazolam
(Versed̉)
|
50 mg/50 mL NS
(1 mg/mL)
|
0.5-2 mg/mL in D5W or NS
May be diluted per request
|
|
Milrinone
(Primacor̉)
|
Load: May be given
undiluted
(1
mg/mL vial)
IV infusion: 20 mg/100 mL D5W
(0.2 mg/mL) pre-made
|
100 mg/250 mL in D5W or NS
(0.4 mg/mL)
|
|
Morphine
|
Infusion: 100 mg/100 mL D5W
(1
mg/mL)
PCA: 300 mg/30 mL SW
(10
mg/mL)
|
May be diluted per request to yield various concentrations
|
|
Nicardipine
(Cardenẻ)
|
0.1 mg/mL in NS
(25 mg/250 mL, 50 mg/500 mL)
|
0.2 mg/mL in NS or D5W
(50 mg/250 mL), must be in central line
|
|
Nitroglycerin
|
50 mg/250 mL D5W glass bottle
(200 mcg/mL)
|
25-400 mcg/mL
(100 mg/250 mL)
D5W or NS glass bottle
Some institutions report up to
800 mcg/mL (200 mg/250 mL)
|
|
Nitroprusside
(Nitropress̉)
|
50 mg/250 mL in D5W
(200 mcg/mL)
Must be properly protected from light
|
50-400 mcg/mL in D5W or NS
(100 mg/250 mL)
Some institutions report up to
800 mcg/mL (200 mg/250 mL)
|
|
Norepinephrine
(Levophed̉)
|
4 mg/250 mL D5W
(16 mcg/mL)
(NS alone not recommended due to loss of potency from
oxidation)
|
4-64 mcg/mL in D5W or D5W ½ NS
(16 mg/250 mL)
Some institutions report 80-128 mcg/mL
(20-32 mg/250 mL)
|
|
Octreotide
(Sandostatin̉)
|
IV bolus: may be given undiluted
Infusion: 500 mcg/100 mL NS bag
(5
mcg/mL)
|
10 mcg/mL in NS or D5W bag or glass
May be diluted per request
|
|
Pancuronium
(Pavulon̉)
|
IV bolus: may be given undiluted
(1
mg/mL)
Infusion: 100 mg/100 mL undiluted
(1
mg/mL)
|
1 mg/mL
Train-of-Four monitoring
|
|
Phenylephrine
(Neosynephrinẻ)
|
10 mg/250 mL NS
(40 mcg/mL)
|
20-160 mcg/mL in NS or D5W
(40 mg/250 mL)
Some institutions report up to
400 mcg/mL (100
mg/250 mL)
|
|
Procainamide
(Pronestyl̉)
|
Load: 500-1000 mg diluted to a final concentration of
20-30 mg/mL D5W
Infusion: 1000 mg/250 mL D5W
(4
mg/mL)
|
16 mg/mL in D5W or NS for infusion
(4000 mg/250 mL)
|
|
Propofol
(Diprivan̉)
|
1000 mg/100 mL glass bottle
(10 mg/mL)
1% Lipid emulsion, 1.1 Kcal/mL
|
10 mg/mL undiluted drug
May be further diluted using only D5W to a concentration
no less than 2 mg/mL
|
|
Tirofiban (Aggrastat̉)
|
12.5 mg/250 mL bag
(50 mcg/mL)
|
50 mcg/mL in NS or D5W
Patients may also receive heparin
|
|
Vecuronium
(Norcuron̉)
|
100 mg/100 mL NS
(1 mg/mL)
|
0.1-1 mg/mL in NS or D5W
Train-of-Four monitoring
|
Information compiled
using clinical practice guidelines from the University of Kansas, University of
Iowa and University of Virginia Surgery Service Center.
Sodorff, MM, Galt, KA, Galt, M, Foral, PA. Recommended Maximum Concentrations of Common
Acute Care Parenteral Admixtures.
Hospital Pharmacy. Volume 34, Number 8, pp 937-942.
Gahart, BL, Nazareno, AR.
2001 Intravenous Medications, 17th Edition.
Table prepared by Kristen A. Brown Pharm.D.